A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Related studies linked through entity extraction aliases.